Celularity (CELU)
(Delayed Data from NSDQ)
$2.07 USD
-0.11 (-5.05%)
Updated Sep 24, 2025 04:00 PM ET
After-Market: $2.05 -0.02 (-0.97%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CELU 2.07 -0.11(-5.05%)
Will CELU be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CELU based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for CELU
200 Day Moving Average Resistance appears for CELU after 2.83% move
CELU Fell Below 200 Day Moving Average on September 22
200 Day Moving Average Support appears for CELU after 1.37% move
Crossed Above 200 Day Moving Average appears for CELU after 1.86% move
Is CELU poised for a decline? 200 Day Moving Average Resistance shows up after a flat session